GW597599

DRUG4 trials

Sponsors

GlaxoSmithKline, Accenture

Conditions

Nausea and Vomiting, PostoperativePost-Operative Nausea and Vomiting (PONV)Postoperative Nausea and VomitingSleep DisordersSleep Initiation and Maintenance Disorders

Phase 1

Single Dose Safety Study for Compound to Treat Post-Operative Nausea and Vomiting (PONV)

CompletedNCT01290133

AccenturePost-Operative Nausea and Vomiting (PONV)

Start: 2011-05-31End: 2011-10-31Updated: 2011-10-13

Phase 2

Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

CompletedNCT00600990

GlaxoSmithKlineNausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting

Start: 2004-12-31End: 2006-07-31Updated: 2017-01-20

A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

CompletedNCT00606697

GlaxoSmithKlineSleep Initiation and Maintenance Disorders

Start: 2007-12-19End: 2008-05-07Updated: 2017-07-11

Vestipitant 28-day Tolerance Study

CompletedNCT00992160

GlaxoSmithKlineSleep Disorders

Start: 2009-05-31End: 2009-09-30Updated: 2016-10-28